RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT. Financials Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
Equities
RICHTER
HU0000123096
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9,200 HUF | +1.38% |
|
+3.90% | +5.14% |
| Mar. 25 | Gedeon Richter Plc. Proposes Dividend | CI |
| Feb. 29 | Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,193,129 | 1,381,559 | 1,619,625 | 1,542,290 | 1,627,029 | 1,681,511 | - | - |
| Enterprise Value (EV) 1 | 1,062,663 | 1,239,491 | 1,559,769 | 1,395,557 | 1,546,536 | 1,545,120 | 1,459,530 | 1,286,374 |
| P/E ratio | 24.2 x | 13.2 x | 11.6 x | 9.94 x | 10.2 x | 7.6 x | 6.87 x | 5.96 x |
| Yield | 0.98% | 3.02% | 2.58% | 4.7% | - | 4.91% | 5.76% | 6.71% |
| Capitalization / Revenue | 2.35 x | 2.44 x | 2.57 x | 1.92 x | 2.02 x | 1.99 x | 1.82 x | 1.65 x |
| EV / Revenue | 2.09 x | 2.19 x | 2.47 x | 1.74 x | 1.92 x | 1.83 x | 1.58 x | 1.26 x |
| EV / EBITDA | 9.53 x | 8.19 x | 8.86 x | 7.1 x | 6.43 x | 4.76 x | 3.9 x | 3.18 x |
| EV / FCF | 26.1 x | 18.3 x | -460 x | 12.3 x | 17.9 x | 7.72 x | 7.37 x | 5.64 x |
| FCF Yield | 3.83% | 5.47% | -0.22% | 8.12% | 5.6% | 13% | 13.6% | 17.7% |
| Price to Book | 1.66 x | 1.72 x | 1.78 x | 1.47 x | - | 1.36 x | 1.24 x | 1.08 x |
| Nbr of stocks (in thousands) | 185,991 | 185,693 | 185,630 | 185,818 | 185,946 | 182,773 | - | - |
| Reference price 2 | 6,415 | 7,440 | 8,725 | 8,300 | 8,750 | 9,200 | 9,200 | 9,200 |
| Announcement Date | 2/7/20 | 2/26/21 | 3/2/22 | 2/28/23 | 2/29/24 | - | - | - |
1HUF in Million2HUF
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 507,794 | 566,776 | 630,595 | 802,755 | 805,158 | 842,896 | 923,288 | 1,019,222 |
| EBITDA 1 | 111,534 | 151,330 | 176,123 | 196,480 | 240,625 | 324,859 | 374,345 | 405,002 |
| EBIT 1 | 71,863 | 111,484 | 135,832 | 153,555 | 189,817 | 265,014 | 299,285 | 329,744 |
| Operating Margin | 14.15% | 19.67% | 21.54% | 19.13% | 23.58% | 31.44% | 32.42% | 32.35% |
| Earnings before Tax (EBT) 1 | 51,697 | 115,164 | 146,575 | 165,663 | 171,540 | 249,895 | 287,277 | 335,273 |
| Net income 1 | 49,299 | 104,683 | 139,626 | 155,581 | 158,850 | 221,247 | 248,861 | 290,171 |
| Net margin | 9.71% | 18.47% | 22.14% | 19.38% | 19.73% | 26.25% | 26.95% | 28.47% |
| EPS 2 | 265.0 | 563.0 | 751.0 | 835.0 | 860.0 | 1,211 | 1,339 | 1,544 |
| Free Cash Flow 1 | 40,688 | 67,757 | -3,393 | 113,348 | 86,554 | 200,201 | 197,983 | 228,175 |
| FCF margin | 8.01% | 11.95% | -0.54% | 14.12% | 10.75% | 23.75% | 21.44% | 22.39% |
| FCF Conversion (EBITDA) | 36.48% | 44.77% | - | 57.69% | 35.97% | 61.63% | 52.89% | 56.34% |
| FCF Conversion (Net income) | 82.53% | 64.73% | - | 72.85% | 54.49% | 90.49% | 79.56% | 78.63% |
| Dividend per Share 2 | 63.00 | 225.0 | 225.0 | 390.0 | - | 451.3 | 530.3 | 617.7 |
| Announcement Date | 2/7/20 | 2/26/21 | 3/2/22 | 2/28/23 | 2/29/24 | - | - | - |
1HUF in Million2HUF
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2020 S1 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 S1 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 278,692 | 296,803 | 157,518 | 176,274 | 168,057 | 192,923 | 217,807 | 223,968 | 209,653 | 203,783 | 413,436 | 188,544 | 203,178 | 224,300 |
| EBITDA 1 | 75,796 | 80,719 | 42,943 | 52,461 | - | 64,033 | 77,353 | 11,597 | 65,277 | 52,831 | 118,108 | 61,657 | 59,078 | 77,100 |
| EBIT 1 | 55,935 | 60,800 | 33,134 | 41,898 | - | 51,972 | 64,840 | -740 | 54,131 | 40,882 | 95,013 | 49,398 | 44,974 | 63,100 |
| Operating Margin | 20.07% | 20.48% | 21.04% | 23.77% | - | 26.94% | 29.77% | -0.33% | 25.82% | 20.06% | 22.98% | 26.2% | 22.14% | 28.13% |
| Earnings before Tax (EBT) | - | - | - | 48,416 | - | - | 87,457 | -43,741 | - | - | - | - | - | - |
| Net income 1 | 60,531 | 54,915 | - | 46,518 | 37,906 | 76,532 | 82,417 | -40,422 | 39,036 | 28,743 | 67,936 | - | - | 58,000 |
| Net margin | 21.72% | 18.5% | - | 26.39% | 22.56% | 39.67% | 37.84% | -18.05% | 18.62% | 14.1% | 16.43% | - | - | 25.86% |
| EPS | - | - | - | 250.0 | - | 411.0 | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 8/3/20 | 8/3/21 | 11/8/21 | 3/2/22 | 5/9/22 | 8/3/22 | 11/7/22 | 2/28/23 | 5/12/23 | 8/4/23 | 8/4/23 | 11/8/23 | 2/29/24 | - |
1HUF in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 130,466 | 142,068 | 59,856 | 146,733 | 80,493 | 136,390 | 221,981 | 395,137 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 40,688 | 67,757 | -3,393 | 113,348 | 86,554 | 200,201 | 197,983 | 228,175 |
| ROE (net income / shareholders' equity) | 9.7% | 13.7% | 16.2% | 15.8% | 14.5% | 17.9% | 18.5% | 19.8% |
| ROA (Net income/ Total Assets) | 9.7% | 11.6% | 13.3% | - | 11.7% | 17% | 18% | 18% |
| Assets 1 | 508,169 | 903,624 | 1,046,939 | - | 1,357,495 | 1,301,453 | 1,382,563 | 1,612,063 |
| Book Value Per Share 2 | 3,874 | 4,333 | 4,910 | 5,633 | - | 6,772 | 7,426 | 8,538 |
| Cash Flow per Share 2 | 528.0 | 723.0 | 752.0 | 992.0 | 670.0 | 1,647 | 1,480 | 1,691 |
| Capex 1 | 57,552 | 66,638 | 143,297 | 71,579 | 94,639 | 89,551 | 83,771 | 88,332 |
| Capex / Sales | 11.33% | 11.76% | 22.72% | 8.92% | 11.75% | 10.62% | 9.07% | 8.67% |
| Announcement Date | 2/7/20 | 2/26/21 | 3/2/22 | 2/28/23 | 2/29/24 | - | - | - |
1HUF in Million2HUF
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
9,200
HUF
Average target price
11,671
HUF
Spread / Average Target
+26.86%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +5.14% | 4.57B | |
| +19.62% | 43.34B | |
| +20.44% | 21.96B | |
| +10.86% | 14.09B | |
| +13.07% | 13.64B | |
| +37.46% | 11.43B | |
| -8.59% | 6.86B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +8.46% | 5.22B |
- Stock Market
- Equities
- RICHTER Stock
- Financials Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
